These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22426134)

  • 1. Application of Quality by Design to the characterization of the cell culture process of an Fc-Fusion protein.
    Rouiller Y; Solacroup T; Deparis V; Barbafieri M; Gleixner R; Broly H; Eon-Duval A
    Eur J Pharm Biopharm; 2012 Jun; 81(2):426-37. PubMed ID: 22426134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Process parameter shifting: Part I. Effect of DOT, pH, and temperature on the performance of Epo-Fc expressing CHO cells cultivated in controlled batch bioreactors.
    Trummer E; Fauland K; Seidinger S; Schriebl K; Lattenmayer C; Kunert R; Vorauer-Uhl K; Weik R; Borth N; Katinger H; Müller D
    Biotechnol Bioeng; 2006 Aug; 94(6):1033-44. PubMed ID: 16736530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Process parameter shifting: Part II. Biphasic cultivation-A tool for enhancing the volumetric productivity of batch processes using Epo-Fc expressing CHO cells.
    Trummer E; Fauland K; Seidinger S; Schriebl K; Lattenmayer C; Kunert R; Vorauer-Uhl K; Weik R; Borth N; Katinger H; Müller D
    Biotechnol Bioeng; 2006 Aug; 94(6):1045-52. PubMed ID: 16736532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of the quality by design approach to the drug substance manufacturing process of an Fc fusion protein: towards a global multi-step design space.
    Eon-duval A; Valax P; Solacroup T; Broly H; Gleixner R; Strat CL; Sutter J
    J Pharm Sci; 2012 Oct; 101(10):3604-18. PubMed ID: 22821774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic approach for scale-down model development and characterization of commercial cell culture processes.
    Li F; Hashimura Y; Pendleton R; Harms J; Collins E; Lee B
    Biotechnol Prog; 2006; 22(3):696-703. PubMed ID: 16739951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining process design space for monoclonal antibody cell culture.
    Abu-Absi SF; Yang L; Thompson P; Jiang C; Kandula S; Schilling B; Shukla AA
    Biotechnol Bioeng; 2010 Aug; 106(6):894-905. PubMed ID: 20589669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion of a CHO cell culture process from perfusion to fed-batch technology without altering product quality.
    Meuwly F; Weber U; Ziegler T; Gervais A; Mastrangeli R; Crisci C; Rossi M; Bernard A; von Stockar U; Kadouri A
    J Biotechnol; 2006 May; 123(1):106-16. PubMed ID: 16324762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical characterization of rhEpo-Fc fusion protein expressed in CHO cells.
    Schriebl K; Trummer E; Lattenmayer C; Weik R; Kunert R; Müller D; Katinger H; Vorauer-Uhl K
    Protein Expr Purif; 2006 Oct; 49(2):265-75. PubMed ID: 16861003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of cell culture process changes on endogenous retrovirus expression.
    Brorson K; De Wit C; Hamilton E; Mustafa M; Swann PG; Kiss R; Taticek R; Polastri G; Stein KE; Xu Y
    Biotechnol Bioeng; 2002 Nov; 80(3):257-67. PubMed ID: 12226857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A predictive high-throughput scale-down model of monoclonal antibody production in CHO cells.
    Legmann R; Schreyer HB; Combs RG; McCormick EL; Russo AP; Rodgers ST
    Biotechnol Bioeng; 2009 Dec; 104(6):1107-20. PubMed ID: 19623562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioprocess development for the production of a recombinant MUC1 fusion protein expressed by CHO-K1 cells in protein-free medium.
    Link T; Bäckström M; Graham R; Essers R; Zörner K; Gätgens J; Burchell J; Taylor-Papadimitriou J; Hansson GC; Noll T
    J Biotechnol; 2004 May; 110(1):51-62. PubMed ID: 15099905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of quality by design principles to the development and technology transfer of a major process improvement for the manufacture of a recombinant protein.
    Looby M; Ibarra N; Pierce JJ; Buckley K; O'Donovan E; Heenan M; Moran E; Farid SS; Baganz F
    Biotechnol Prog; 2011; 27(6):1718-29. PubMed ID: 21948302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twenty-four well plate miniature bioreactor system as a scale-down model for cell culture process development.
    Chen A; Chitta R; Chang D; Amanullah A
    Biotechnol Bioeng; 2009 Jan; 102(1):148-60. PubMed ID: 18683260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of bioreactor design principles and multivariate analysis for development of cell culture scale down models.
    Tescione L; Lambropoulos J; Paranandi MR; Makagiansar H; Ryll T
    Biotechnol Bioeng; 2015 Jan; 112(1):84-97. PubMed ID: 25042258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of a fed-batch process for TNFR-fc producing GS-CHO cells].
    Fan L; Zhao L; Sun Y; Kou T; Tan W
    Sheng Wu Gong Cheng Xue Bao; 2010 Feb; 26(2):216-22. PubMed ID: 20432941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel micro-bioreactor high throughput technology for cell culture process development: Reproducibility and scalability assessment of fed-batch CHO cultures.
    Amanullah A; Otero JM; Mikola M; Hsu A; Zhang J; Aunins J; Schreyer HB; Hope JA; Russo AP
    Biotechnol Bioeng; 2010 May; 106(1):57-67. PubMed ID: 20073088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming challenges in WAVE Bioreactors without feedback controls for pH and dissolved oxygen.
    Yuk IH; Baskar D; Duffy PH; Hsiung J; Leung S; Lin AA
    Biotechnol Prog; 2011; 27(5):1397-406. PubMed ID: 21987370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a scale down cell culture model using multivariate analysis as a qualification tool.
    Tsang VL; Wang AX; Yusuf-Makagiansar H; Ryll T
    Biotechnol Prog; 2014; 30(1):152-60. PubMed ID: 24124180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH measurement and a rational and practical pH control strategy for high throughput cell culture system.
    Zhou H; Purdie J; Wang T; Ouyang A
    Biotechnol Prog; 2010; 26(3):872-80. PubMed ID: 20039376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of human IL-35-IgG4 (Fc) fusion protein in CHO/DG44 cells].
    Tang J; Gao W; Zhang Q; Zhang D; Chen Y; He B; Liu Q
    Sheng Wu Gong Cheng Xue Bao; 2009 Jan; 25(1):109-15. PubMed ID: 19441235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.